Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P McGlave

Showing results (21-30 of 63) with videos related to

Pageof 7
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1993
Unrelated-donor bone marrow transplantation for Philadelphia chromosome-positive chronic myelogenous leukemia in childrenA S Gamis, R Haake, P McGlave, et al.
Hepatology (Baltimore, Md.)|March 1, 1989
Nodular regenerative hyperplasia of the liver following bone marrow transplantationD C Snover, S Weisdorf, J Bloomer, et al.
Bone Marrow Transplantation|February 1, 1995
Lupus inhibitors following bone marrow transplantE W Greeno, R Haake, P McGlave, et al.
JAMA|June 10, 1988
Effectiveness of a regional bone marrow donor programJ McCullough, E P Scott, N Halagan, et al.
American Journal of Hematology|March 1, 1985
Bronchiolitis obliterans after bone marrow transplantationM E Rosenberg, G M Vercellotti, D C Snover, et al.
Journal of Clinical Immunology|July 1, 1982
Treatment of donor bone marrow with OKT3 (PAN-T monoclonal antibody) for prophylaxis of graft-vs.-host disease (GvHD) in histocompatible allogeneic bone marrow transplantation (BMT): a pilot studyA H Filipovich, P McGlave, N K Ramsay, et al.
Bone Marrow Transplantation|September 1, 1991
Candida infections in bone marrow transplant recipientsC Verfaillie, D Weisdorf, R Haake, et al.
Blood|September 1, 1987
Unrelated donor bone marrow transplantation therapy for chronic myelogenous leukemiaP McGlave, E Scott, N Ramsay, et al.
Bone Marrow Transplantation|October 1, 1994
Large scale ex vivo expansion and activation of human natural killer cells for autologous therapyJ S Miller, S Klingsporn, J Lund, et al.
Bone Marrow Transplantation|November 1, 1993
Combination graft-versus-host disease prophylaxis using immunotoxin (anti-CD5-RTA [Xomazyme-CD5]) plus methotrexate and cyclosporine or prednisone after unrelated donor marrow transplantationD Weisdorf, A Filipovich, P McGlave, et al.
Pageof 7

Showing results (21-30 of 63) with videos related to

Sort By:
Pageof 7
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1993
Unrelated-donor bone marrow transplantation for Philadelphia chromosome-positive chronic myelogenous leukemia in childrenA S Gamis, R Haake, P McGlave, et al.
Hepatology (Baltimore, Md.)|March 1, 1989
Nodular regenerative hyperplasia of the liver following bone marrow transplantationD C Snover, S Weisdorf, J Bloomer, et al.
Bone Marrow Transplantation|February 1, 1995
Lupus inhibitors following bone marrow transplantE W Greeno, R Haake, P McGlave, et al.
JAMA|June 10, 1988
Effectiveness of a regional bone marrow donor programJ McCullough, E P Scott, N Halagan, et al.
American Journal of Hematology|March 1, 1985
Bronchiolitis obliterans after bone marrow transplantationM E Rosenberg, G M Vercellotti, D C Snover, et al.
Journal of Clinical Immunology|July 1, 1982
Treatment of donor bone marrow with OKT3 (PAN-T monoclonal antibody) for prophylaxis of graft-vs.-host disease (GvHD) in histocompatible allogeneic bone marrow transplantation (BMT): a pilot studyA H Filipovich, P McGlave, N K Ramsay, et al.
Bone Marrow Transplantation|September 1, 1991
Candida infections in bone marrow transplant recipientsC Verfaillie, D Weisdorf, R Haake, et al.
Blood|September 1, 1987
Unrelated donor bone marrow transplantation therapy for chronic myelogenous leukemiaP McGlave, E Scott, N Ramsay, et al.
Bone Marrow Transplantation|October 1, 1994
Large scale ex vivo expansion and activation of human natural killer cells for autologous therapyJ S Miller, S Klingsporn, J Lund, et al.
Bone Marrow Transplantation|November 1, 1993
Combination graft-versus-host disease prophylaxis using immunotoxin (anti-CD5-RTA [Xomazyme-CD5]) plus methotrexate and cyclosporine or prednisone after unrelated donor marrow transplantationD Weisdorf, A Filipovich, P McGlave, et al.
Pageof 7